Datar cancer genetics announces foray into the United States with a $250m contract to offer pioneering cancer detection liquid biopsies
Datar Cancer Genetics (Datar), a world-leading cancer research corporation today announced a USD 250 million contract with Artemis DNA, a leading USA-based di
Source: texasguardian.com